News & Insights
All News & Insights
Biofourmis Named 2021 DPHARM Idol Disrupt Winner
Biofourmis Named 2021 DPHARM Idol Disrupt Winner
Judges lauded Biofourmis’ rapid growth and the ability of its artificial intelligence (AI)-powered Biovitals® platform to remotely collect and analyze clinical biomarkers of trial participants.
Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Medicine for Heart Failure
Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Medicine for Heart Failure
We are taking personalized, predictive care to new heights as BioVitalsHF is the first-ever digital medicine to receive a breakthrough exemption from the FDA for patients with heart failure.
Digital Health Leader Maulik Majmudar, MD, Joins Biofourmis as Chief Medical Officer to Accelerate Company's Move to Become the Most Comprehensive Care-at-Home Platform
Digital Health Leader Maulik Majmudar, MD, Joins Biofourmis as Chief Medical Officer to Accelerate Company's Move to Become the Most Comprehensive Care-at-Home Platform
Former Amazon Medical Officer and Massachusetts General Hospital Cardiologist to Lead Product Management, Data Science and Clinical Affairs for Biofourmis.
Biofourmis Announces National Rollout of the Biovitals® Hospital@Home™ Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program
Biofourmis Announces National Rollout of the Biovitals® Hospital@Home™ Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program
Biofourmis announces national rollout of the Biovitals® Hospital@Home™ platform to help deliver Hospital-Level Care in the home aligned with new CMS Program, providing coverage for hospital at home providers.
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Led by SoftBank Vision Fund 2 , Biofourmis closed a $100 Million Series C funding round to accelerate U.S. and Global Expansion
Biofourmis' AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore
Biofourmis' AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore
Biovitals has been deployed by the Ministry of Health in Singapore to remotely monitor COVID-19 patients to aid in early detection and to enable clinicians to intervene early.
Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology
Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology
Chugai Pharmaceutical Co. Ltd and our digital medicine company have partnered to develop an objective assessment of pain using digital technology.
Biofourmis names new CFO to help drive the digital medicine start-up's growth plans
Biofourmis names new CFO to help drive the digital medicine start-up's growth plans
Biofourmis names new CFO, Matt Borowiecki to help drive the digital medicine start-up’s growth plans.
Digital Medicine Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Digital Medicine Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Our digital medicine company announced it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals expanding our portfolio into Oncology.